Calreticulin: Non-endoplasmic reticulum functions in physiology and disease

FASEB Journal

Volumn 24, Issue 3, 2010, Pages 665-683

  Gold, Leslie I ^a   Eggleton, Paul ^e   Sweetwyne, Mariya T ^c   Van Duyn, Lauren B ^b,d   Greives, Matthew R ^a,g   Naylor, Sara Megumi ^a   Michalak, Marek ^f   Murphy Ullrich, Joanne E ^b,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF EXETER   (United Kingdom)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

Extracellular matrix; Migration; Phagocytosis; Tumor recognition; Wound healing

Indexed keywords

CALRETICULIN; FOCAL ADHESION KINASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADAPTIVE IMMUNITY; ANOIKIS; CELL ADHESION; CELL MIGRATION; CELL SURFACE; ENDOPLASMIC RETICULUM; EPITHELIZATION; EXTRACELLULAR MATRIX; FOCAL ADHESION; HUMAN; IMMUNOBLOTTING; IMMUNOREGULATION; NEOPLASM; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; BIOLOGICAL MODEL; CELL MOTION; CYTOSOL; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ANIMALIA;

ANIMALS; CALRETICULIN; CELL MOVEMENT; CYTOSOL; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; HUMANS; MODELS, BIOLOGICAL; PHAGOCYTOSIS;

EID: 77952293789     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-145482     Document Type: Review

References (167)

1. Bedard, K., Szabo, E., Michalak, M., and Opas, M. (2005) Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int. Rev. Cytol. 245, 91-121
2. Michalak, M., Groenendyk, J., Szabo, E., Gold, L. I., and Opas, M. (2009) Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem. J. 417, 651-666
3. Mesaeli, N., Nakamura, K., Zvaritch, E., Dickie, P., Dziak, E., Krause, K. H., Opas, M., MacLennan, D. H., and Michalak, M. (1999) Calreticulin is essential for cardiac development. J. Cell Biol. 144, 857-868
4. Tesniere, A., Apetoh, L., Ghiringhelli, F., Joza, N., Panaretakis, T., Kepp, O., Schlemmer, F., Zitvogel, L., and Kroemer, G. (2008) Immunogenic cancer cell death: a key-lock paradigm. Curr. Opin. Immunol. 20, 504-511
5. Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J. L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., Metivier, D., Larochette, N., van Endert, P., Ciccosanti, F., Piacentini, M., Zitvogel, L., and Kroemer, G. (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54-61 (Pubitemid 46067386)
6. Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P. A., Michalak, M., and Henson, P. M. (2005) Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321-334
7. Nanney, L. B., Woodrell, C. D., Greives, M. R., Cardwell, N. L., Pollins, A. C., Bancroft, T. A., Chesser, A., Michalak, M., Rahman, M., Siebert, J. W., and Gold, L. I. (2008) Calreticulin enhances porcine wound repair by diverse biological effects. Am. J. Pathol. 173, 610-630
8. Coppolino, M. G., and Dedhar, S. (1999) Ligand-specific, transient interaction between integrins and calreticulin during cell adhesion to extracellular matrix proteins is dependent upon phosphorylation/ dephosphorylation events. Biochem. J. 340, 41-50
9. Coppolino, M. G., and Dedhar, S. (2000) Bi-directional signal transduction by integrin receptors. Int. J. Biochem. Cell Biol. 32, 171-188
10. Coppolino, M. G., Woodside, M. J., Demaurex, N., Grinstein, S., St-Arnaud, R., and Dedhar, S. (1997) Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature 386, 843-847
11. Orr, A. W., Elzie, C. A., Kucik, D. F., and Murphy-Ullrich, J. E. (2003) Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J. Cell Sci. 116, 2917-2927
12. Orr, A. W., Pallero, M. A., and Murphy-Ullrich, J. E. (2002) Thrombospondin stimulates focal adhesion disassembly through Gi- and phosphoinositide 3-kinase-dependent ERK activation. J. Biol. Chem. 277, 20453-20460
13. Orr, A. W., Pallero, M. A., Xiong, W. C., and Murphy-Ullrich, J. E. (2004) Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly. J. Biol. Chem. 279, 48983-48992
14. Goicoechea, S., Orr, A. W., Pallero, M. A., Eggleton, P., and Murphy-Ullrich, J. E. (2000) Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin. J. Biol. Chem. 275, 36358-36368
15. Goicoechea, S., Pallero, M. A., Eggleton, P., Michalak, M., and Murphy-Ullrich, J. E. (2002) The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin. J. Biol. Chem. 277, 37219-37228
16. Pallero, M. A., Elzie, C. A., Chen, J., Mosher, D. F., and Murphy-Ullrich, J. E. (2008) Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. FASEB J. 22, 3968-3979
17. Orr, A. W., Pedraza, C. E., Pallero, M. A., Elzie, C. A., Goicoechea, S., Strickland, D. K., and Murphy-Ullrich, J. E. (2003) Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly. J. Cell Biol. 161, 1179-1189
18. Panaretakis, T., Joza, N., Modjtahedi, N., Tesniere, A., Vitale, I., Durchschlag, M., Fimia, G. M., Kepp, O., Piacentini, M., Froehlich, K. U., van Endert, P., Zitvogel, L., Madeo, F., and Kroemer, G. (2008) The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ. 15, 1499-1509
19. Ling, S., Pi, X., and Holoshitz, J. (2007) The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin. J. Immunol. 179, 6359-6367
20. Arosa, F. A., de Jesus, O., Porto, G., Carmo, A. M., and de Sousa, M. (1999) Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules. J. Biol. Chem. 274, 16917-16922
21. Sadasivan, B., Lehner, P. J., Ortmann, B., Spies, T., and Cresswell, P. (1996) Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5, 103-114
22. White, T. K., Zhu, Q., and Tanzer, M. L. (1995) Cell surface calreticulin is a putative mannoside lectin which triggers mouse melanoma cell spreading. J. Biol. Chem. 270, 15926-15929
23. Gray, A. J., Park, P. W., Broekelmann, T. J., Laurent, G. J., Reeves, J. T., Stenmark, K. R., and Mecham, R. P. (1995) The mitogenic effects of the B beta chain of fibrinogen are mediated through cell surface calreticulin. J. Biol. Chem. 270, 26602-26606
24. Ogden, C. A., deCathelineau, A., Hoffmann, P. R., Bratton, D., Ghebrehiwet, B., Fadok, V. A., and Henson, P. M. (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194, 781-795
25. Tarr, J., and Eggleton, P. (2005) Immune function of C1q and its modulators CD91 and CD93. Crit. Rev. Immunol. 25, 305-330
26. Dedhar, S. (1994) Novel functions for calreticulin: interaction with integrins and modulation of gene expression? Trends Biochem. Sci. 19, 269-271
27. Coppolino, M., Leung-Hagesteijn, C., Dedhar, S., and Wilkins, J. (1995) Inducible interaction of integrin alpha 2 beta 1 with calreticulin. Dependence on the activation state of the integrin. J. Biol. Chem. 270, 23132-23138
28. Tran, H., Pankov, R., Tran, S. D., Hampton, B., Burgess, W. H., and Yamada, K. M. (2002) Integrin clustering induces kinectin accumulation. J. Cell Sci. 115, 2031-2040 (Pubitemid 34746370)
29. Kreis, S., Schonfeld, H. J., Melchior, C., Steiner, B., and Kieffer, N. (2005) The intermediate filament protein vimentin binds specifically to a recombinant integrin alpha2/beta1 cytoplasmic tail complex and co-localizes with native alpha2/beta1 in endothelial cell focal adhesions. Exp. Cell. Res. 305, 110-121
30. Elton, C. M., Smethurst, P. A., Eggleton, P., and Farndale, R. W. (2002) Physical and functional interaction between cell-surface calreticulin and the collagen receptors integrin alpha2beta1 and glycoprotein VI in human platelets. Thromb. Haemost. 88, 648-654 (Pubitemid 35174009)
31. Rauch, F., Prud'homme, J., Arabian, A., Dedhar, S., and St-Arnaud, R. (2000) Heart, brain, and body wall defects in mice lacking calreticulin. Exp. Cell. Res. 256, 105-111
32. Frisch, S. M., and Screaton, R. A. (2001) Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555-562
33. Frisch, S. M., and Francis, H. (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626
34. Murphy-Ullrich, J. E. (2001) The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J. Clin. Invest. 107, 785-790
35. Zouq, N. K., Keeble, J. A., Lindsay, J., Valentijn, A. J., Zhang, L., Mills, D., Turner, C. E., Streuli, C. H., and Gilmore, A. P. (2009) FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: differential roles for paxillin and p130Cas. J. Cell Sci. 122, 357-367
36. Gilmore, A. P. (2005) Anoikis. Cell Death Differ. 12(Suppl. 2), 1473-1477
37. Boudreau, N., Sympson, C. J., Werb, Z., and Bissell, M. J. (1995) Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893
38. Valentijn, A. J., Zouq, N., and Gilmore, A. P. (2004) Anoikis. Biochem. Soc. Trans. 32, 421-425
39. Michel, J. B. (2003) Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler. Thromb. Vasc. Biol. 23, 2146-2154
40. Ortiz-Munoz, G., Houard, X., Martin-Ventura, J. L., Ishida, B. Y., Loyau, S., Rossignol, P., Moreno, J. A., Kane, J. P., Chalkley, R. J., Burlingame, A. L., Michel, J. B., and Meilhac, O. (2009) HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property. FASEB J. 23, 3129-3139
41. Horowitz, J. C., Rogers, D. S., Sharma, V., Vittal, R., White, E. S., Cui, Z., and Thannickal, V. J. (2007) Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell. Signal. 19, 761-771
42. Subramanian, S., Tsai, R., and Discher, D. E. (2006) The 'metabolon,' CD47, and the 'phagocytic synapse': molecular co-localization and species divergence. Transfus. Clin. Biol. 13, 31-38
43. Kuraishi, T., Manaka, J., Kono, M., Ishii, H., Yamamoto, N., Koizumi, K., Shiratsuchi, A., Lee, B. L., Higashida, H., and Nakanishi, Y. (2007) Identification of calreticulin as a marker for phagocytosis of apoptotic cells in Drosophila. Exp. Cell. Res. 313, 500-510
44. Park, Y. J., Liu, G., Lorne, E. F., Zhao, X., Wang, J., Tsuruta, Y., Zmijewski, J., and Abraham, E. (2008) PAI-1 inhibits neutrophil efferocytosis. Proc. Natl. Acad. Sci. U. S. A. 105, 11784-11789
45. Gaipl, U. S., Sheriff, A., Franz, S., Munoz, L. E., Voll, R. E., Kalden, J. R., and Herrmann, M. (2006) Inefficient clearance of dying cells and autoreactivity. Curr. Top. Microbiol. Immunol. 305, 161-176 (Pubitemid 47400269)
46. Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., and Nagata, S. (2004) Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304, 1147-1150
47. Henson, P. M., and Hume, D. A. (2006) Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 27, 244-250
48. Eggleton, P., and Llewellyn, D. H. (1999) Pathophysiological roles of calreticulin in autoimmune disease. Scand. J. Immunol. 49, 466-473
49. Honore, C., Hummelshoj, T., Hansen, B. E., Madsen, H. O., Eggleton, P., and Garred, P. (2007) The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum. 56, 1598-1607
50. Eggleton, P., Lieu, T. S., Zappi, E. G., Sastry, K., Coburn, J., Zaner, K. S., Sontheimer, R. D., Capra, J. D., Ghebrehiwet, B., and Tauber, A. I. (1994) Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin. Immunol. Immunopathol. 72, 405-409
51. Donnelly, S., Roake, W., Brown, S., Young, P., Naik, H., Wordsworth, P., Isenberg, D. A., Reid, K. B., and Eggleton, P. (2006) Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum. 54, 1543-1556
52. Duus, K., Hansen, P. R., and Houen, G. (2008) Interaction of calreticulin with amyloid beta peptide 1-42. Protein Pept. Lett. 15, 103-107
53. Aguilar, L., Ramirez, G., Valck, C., Molina, M. C., Rojas, A., Schwaeble, W., Ferreira, V., and Ferreira, A. (2005) F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement. Biol. Res. 38, 187-195
54. Ribeiro, C. H., Lopez, N. C., Ramirez, G. A., Valck, C. E., Molina, M. C., Aguilar, L., Rodriguez, M., Maldonado, I., Martinez, R., Gonzalez, C., Troncoso, R., Lavandero, S., Gingras, A. R., Schwaeble, W., and Ferreira, A. (2009) Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Mol. Immunol. 46, 1092-1099
55. Zhu, Q., Zelinka, P., White, T., and Tanzer, M. L. (1997) Calreticulin-integrin bidirectional signaling complex. Biochem. Biophys. Res. Commun. 232, 354-358
56. Panaretakis, T., Kepp, O., Brockmeier, U., Tesniere, A., Bjorklund, A. C., Chapman, D. C., Durchschlag, M., Joza, N., Pierron, G., van Endert, P., Yuan, J., Zitvogel, L., Madeo, F., Williams, D. B., and Kroemer, G. (2009) Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J. 28, 578-590
57. Vance, B. A., Harley, P. H., Backlund, P. S., Ward, Y., Phelps, T. L., and Gress, R. E. (2005) Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface. Arch. Biochem. Biophys. 438, 11-20
58. Somogyi, E., Petersson, U., Hultenby, K., and Wendel, M. (2003) Calreticulin - an endoplasmic reticulum protein with calcium-binding activity is also found in the extracellular matrix. Matrix Biol. 22, 179-191
59. Kypreou, K. P., Kavvadas, P., Karamessinis, P., Peroulis, M., Alberti, A., Sideras, P., Psarras, S., Capetanaki, Y., Politis, P. K., and Charonis, A. S. (2008) Altered expression of calreticulin during the development of fibrosis. Proteomics 8, 2407-2419
60. McDonnell, J. M., Jones, G. E., White, T. K., and Tanzer, M. L. (1996) Calreticulin binding affinity for glycosylated laminin. J. Biol. Chem. 271, 7891-7894
61. Peerschke, E., and Ghebrehiwet, B. (1990) Platelet C1q receptor interactions with collagen- and C1q-coated surfaces. J. Immunol. 145, 2984-2988 (Pubitemid 20382570)
62. Wu, M., Massaeli, H., Durston, M., and Mesaeli, N. (2007) Differential expression and activity of matrix metalloproteinase- 2 and -9 in the calreticulin deficient cells. Matrix Biol. 26, 463-472
63. Gailit, J., and Clark, R. A. (1994) Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. 6, 717-725 (Pubitemid 24295306)
64. Singer, A. J., and Clark, R. A. (1999) Cutaneous wound healing. N. Engl. J. Med. 341, 738-746
65. Mesaeli, N., and Phillipson, C. (2004) Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. Mol. Biol. Cell 15, 1862-1870 (Pubitemid 38401834)
66. Jalali, S., Aghasi, M., Yeganeh, B., and Mesaeli, N. (2008) Calreticulin regulates insulin receptor expression and its downstream PI3 Kinase/Akt signalling pathway. Biochim. Biophys. Acta 1783, 2344-2351
67. Yoon, G. S., Lee, H., Jung, Y., Yu, E., Moon, H. B., Song, K., and Lee, I. (2000) Nuclear matrix of calreticulin in hepatocellular carcinoma. Cancer Res. 60, 1117-1120
68. Tutuncu, L., Stein, P., Ord, T. S., Jorgez, C. J., and Williams, C. J. (2004) Calreticulin on the mouse egg surface mediates transmembrane signaling linked to cell cycle resumption. Dev. Biol. 270, 246-260
69. Sezestakowska, D., Szabo, E., Eggleton, P., Opas, M., and Young, P. (2006) 7th International Workshop on Calreticulin, Niagara Falls, Canada: the complexities of calreticulin from folding to disease prevention and therapeutic application. Calcium Binding Proteins 1, 135-139
70. Yao, L., Pike, S. E., Pittaluga, S., Cherney, B., Gupta, G., Jaffe, E. S., and Tosato, G. (2002) Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin. Cancer Immunol. Immunother. 51, 358-366
71. Cai, K. X., Tse, L. Y., Leung, C., Tam, P. K., Xu, R., and Sham, M. H. (2008) Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin. Clin. Cancer Res. 14, 939-949
72. Jazowiecka-Rakus, J., Jarosz, M., Kozlowska, D., Sochanik, A., and Szala, S. (2007) Combination of vasostatin and cyclophosphamide in the therapy of murine melanoma tumors. Acta Biochim. Pol. 54, 125-133 (Pubitemid 46481825)
73. Yao, L., Pike, S. E., and Tosato, G. (2002) Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function. J. Leukoc. Biol. 71, 47-53 (Pubitemid 34062771)
74. Pike, S. E., Yao, L., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H., Teruya-Feldstein, J., Wirth, P., Gupta, G., and Tosato, G. (1998) Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J. Exp. Med. 188, 2349-2356 (Pubitemid 29028507)
75. Lange-Asschenfeldt, B., Velasco, P., Streit, M., Hawighorst, T., Pike, S. E., Tosato, G., and Detmar, M. (2001) The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting doses. J. Invest. Dermatol. 117, 1036-1041 (Pubitemid 34205895)
76. Li, W. Y., Huang, E. Y., Dudas, M., Kaartinen, V., Warburton, D., and Tuan, T. L. (2006) Transforming growth factor-β3 affects plasminogen activator inhibitor-1 expression in fetal mice and modulates fibroblast-mediated collagen gel contraction. Wound Repair Regen. 14, 516-525
77. Wu, L., Siddiqui, A., Morris, D. E., Cox, D. A., Roth, S. I., and Mustoe, T. A. (1997) Transforming growth factor β3 (TGF β3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studies. Arch. Surg. 132, 753-760 (Pubitemid 27305229)
78. Ferguson, M. W., Duncan, J., Bond, J., Bush, J., Durani, P., So, K., Taylor, L., Chantrey, J., Mason, T., James, G., Laverty, H., Occleston, N. L., Sattar, A., Ludlow, A., and O'Kane, S. (2009) Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet 373, 1264-1274
79. Schor, S. L., Ellis, I. R., Harada, K., Motegi, K., Anderson, A. R., Chaplain, M. A., Keatch, R. P., and Schor, A. M. (2006) A novel 'sandwich' assay for quantifying chemo-regulated cell migration within 3-dimensional matrices: wound healing cytokines exhibit distinct motogenic activities compared to the transmembrane assay. Cell. Motil. Cytoskeleton 63, 287-300
80. Ellis, I. R., Banyard, J., and Schor, S. L. (1999) Motogenic and biosynthetic response of adult skin fibroblasts to TGF-β isoforms (-1, -2 and -3) determined by 'tissue response unit': role of cell density and substratum. Cell Biol. Int. 23, 593-602
81. Bandyopadhyay, B., Fan, J., Guan, S., Li, Y., Chen, M., Woodley, D. T., and Li, W. (2006) A "traffic control" role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healing. J. Cell Biol. 172, 1093-1105
82. Leonard, C. M., Fuld, H. M., Frenz, D. A., Downie, S. A., Massague, J., and Newman, S. A. (1991) Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-β and evidence for endogenous TGF-β-like activity. Dev. Biol. 145, 99-109 (Pubitemid 121004243)
83. Papp, S., Fadel, M. P., Kim, H., McCulloch, C. A., and Opas, M. (2007) Calreticulin affects fibronectin-based cell-substratum adhesion via the regulation of c-Src activity. J. Biol. Chem. 282, 16585-16598 (Pubitemid 47100404)
84. Papp, S., Szabo, E., Kim, H., McCulloch, C.A., and Opas, M. (2008) Kinase-dependent adhesion to fibronectin: regulation by calreticulin. Exp. Cell Res. 314, 1313
85. Agah, A., Kyriakides, T. R., Letrondo, N., Bjorkblom, B., and Bornstein, P. (2004) Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis. Matrix. Biol. 22, 539-547 (Pubitemid 38283777)
86. Raugi, G. J., Olerud, J. E., and Gown, A. M. (1987) Thrombospondin in early human wound tissue. J. Invest. Dermatol. 89, 551-554
87. Reilly, D., Larkin, D., Devocelle, M., Fitzgerald, D. J., and Moran, N. (2004) Calreticulin-independent regulation of the platelet integrin αIIbβ3 by the KVGFFKR αIIb-cytoplasmic motif. Platelets 15, 43-54
88. Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M., Lawler, J., Hynes, R. O., Boivin, G. P., and Bouck, N. (1998) Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93, 1159-1170 (Pubitemid 28307421)
89. Ahmed, Z., and Bicknell, R. (2009) Angiogenic signalling pathways. Methods Mol. Biol. 467, 3-24
90. Nishi, H., Nakada, T., Hokamura, M., Osakabe, Y., Itokazu, O., Huang, L. E., and Isaka, K. (2004) Hypoxia-inducible factor-1 transactivates transforming growth factor-β3 in trophoblast. Endocrinology 145, 4113-4118 (Pubitemid 39120559)
91. Brem, H., and Tomic-Canic, M. (2007) Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest. 117, 1219-1222
92. Ochoa, O., Torres, F. M., and Shireman, P. K. (2007) Chemokines and diabetic wound healing. Vascular 15, 350-355
93. Totary-Jain, H., Naveh-Many, T., Riahi, Y., Kaiser, N., Eckel, J., and Sasson, S. (2005) Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions. Circ. Res. 97, 1001-1008
94. Obeid, M., Panaretakis, T., Tesniere, A., Joza, N., Tufi, R., Apetoh, L., Ghiringhelli, F., Zitvogel, L., and Kroemer, G. (2007) Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic. Cancer Res. 67, 7941-7944
95. 2+ levels favors plasma membrane surface exposure of calreticulin. Cell Death Differ. 15, 274-282
96. Chaput, N., De Botton, S., Obeid, M., Apetoh, L., Ghiringhelli, F., Panaretakis, T., Flament, C., Zitvogel, L., and Kroemer, G. (2007) Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference. J. Mol. Med. 85, 1069-1076
97. Obeid, M., Panaretakis, T., Joza, N., Tufi, R., Tesniere, A., van Endert, P., Zitvogel, L., and Kroemer, G. (2007) Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis. Cell Death Differ. 14, 1848-1850
98. Zhang, K., and Kaufman, R. J. (2008) Identification and characterization of endoplasmic reticulum stress-induced apoptosis in vivo. Methods Enzymol. 442, 395-419
99. Obeid, M., Tesniere, A., Panaretakis, T., Tufi, R., Joza, N., van Endert, P., Ghiringhelli, F., Apetoh, L., Chaput, N., Flament, C., Ullrich, E., de Botton, S., Zitvogel, L., and Kroemer, G. (2007) Ecto-calreticulin in immunogenic chemotherapy. Immunol. Rev. 220, 22-34
100. Viaud, S., Terme, M., Flament, C., Taieb, J., Andre, F., Novault, S., Escudier, B., Robert, C., Caillat-Zucman, S., Tursz, T., Zitvogel, L., and Chaput, N. (2009) Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS One 4, e4942
101. Zitvogel, L., Apetoh, L., Ghiringhelli, F., Andre, F., Tesniere, A., and Kroemer, G. (2008) The anticancer immune response: indispensable for therapeutic success? J. Clin. Invest. 118, 1991-2001
102. Hsieh, C. J., Kim, T. W., Hung, C. F., Juang, J., Moniz, M., Boyd, D. A., He, L., Chen, P. J., Chen, C. H., and Wu, T. C. (2004) Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. Vaccine 22, 3993-4001 (Pubitemid 39208763)
103. Cheng, W. F., Hung, C. F., Chen, C. A., Lee, C. N., Su, Y. N., Chai, C. Y., Boyd, D. A., Hsieh, C. Y., and Wu, T. C. (2005) Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis. Vaccine 23, 3864-3874
104. Cheng, W. F., Lee, C. N., Su, Y. N., Chai, C. Y., Chang, M. C., Polo, J. M., Hung, C. F., Wu, T. C., Hsieh, C. Y., and Chen, C. A. (2006) Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity. Cancer Gene Ther. 13, 873-885 (Pubitemid 44239132)
105. Zitvogel, L., Casares, N., Pequignot, M. O., Chaput, N., Albert, M. L., and Kroemer, G. (2004) Immune response against dying tumor cells. Adv. Immunol. 84, 131-179
106. Franz, S., Herrmann, K., Furnrohr, B. G., Sheriff, A., Frey, B., Gaipl, U. S., Voll, R. E., Kalden, J. R., Jack, H. M., and Herrmann, M. (2007) After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes. Cell Death Differ. 14, 733-742
107. Wearsch, P. A., and Cresswell, P. (2008) The quality control of MHC class I peptide loading. Curr. Opin. Cell Biol. 20, 624-631
108. Zhang, Y., Kozlov, G., Pocanschi, C. L., Brockmeier, U., Ireland, B. S., Maattanen, P., Howe, C., Elliott, T., Gehring, K., and Williams, D. B. (2009) ERp57 does not require interactions with calnexin and calreticulin to promote assembly of class I histocompatibility molecules, and it enhances peptide loading independently of its redox activity. J. Biol. Chem. 284, 10160-10173
109. Raghavan, M., Del Cid, N., Rizvi, S. M., and Peters, L. R. (2008) MHC class I assembly: out and about. Trends Immunol. 29, 436-443
110. Apetoh, L., Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Piacentini, M., Kroemer, G., and Zitvogel, L. (2007) Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells. Cancer Genomics Proteomics 4, 65-70 (Pubitemid 46632027)
111. Kepp, O., Tesniere, A., Zitvogel, L., and Kroemer, G. (2009) The immunogenicity of tumor cell death. Curr. Opin. Oncol. 21, 71-76
112. Kepp, O., Tesniere, A., Schlemmer, F., Michaud, M., Senovilla, L., Zitvogel, L., and Kroemer, G. (2009) Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 14, 364-375
113. Zeng, G., Aldridge, M. E., Tian, X., Seiler, D., Zhang, X., Jin, Y., Rao, J., Li, W., Chen, D., Langford, M. P., Duggan, C., Belldegrun, A. S., and Dubinett, S. M. (2006) Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system. J. Immunol. 177, 3582-3589 (Pubitemid 44359889)
114. Kepp, O., Senovilla, L., Galluzzi, L., Panaretakis, T., Tesniere, A., Schlemmer, F., Madeo, F., Zitvogel, L., and Kroemer, G. (2009) Viral subversion of immunogenic cell death. Cell Cycle 8, 860-869
115. Chignard, N., Shang, S., Wang, H., Marrero, J., Brechot, C., Hanash, S., and Beretta, L. (2006) Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. Gastroenterology 130, 2010-2022
116. Neckers, L. (2006) Chaperoning oncogenes: Hsp90 as a target of geldanamycin. In Molecular Chaperones in Health and Disease. Handbook in Experimental Pharmacology, Vol. 172 (Gaestel, M., ed) pp. 259-277, Springer, Berlin
117. Calderwood, S. K., Khaleque, M. A., Sawyer, D. B., and Ciocca, D. R. (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem. Sci. 31, 164-172 (Pubitemid 43361923)
118. Gehrmann, M., Radons, J., Molls, M., and Multhoff, G. (2008) The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. Cell Stress Chaperones 13, 1-10
119. Forslow, A., Liu, Z., and Sundqvist, K. G. (2007) Receptor communication within the lymphocyte plasma membrane: a role for the thrombospondin family of matricellular proteins. Cell. Mol. Life Sci. 64, 66-76 (Pubitemid 46164493)
120. Li, Z., He, L., Wilson, K., and Roberts, D. (2001) Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation. J. Immunol. 166, 2427-2436 (Pubitemid 32173478)
121. Petrovski, G., Zahuczky, G., Majai, G., and Fesus, L. (2007) Phagocytosis of cells dying through autophagy evokes a proinflammatory response in macrophages. Autophagy 3, 509-511 (Pubitemid 47293742)
122. Petrovski, G., Zahuczky, G., Katona, K., Vereb, G., Martinet, W., Nemes, Z., Bursch, W., and Fesus, L. (2007) Clearance of dying autophagic cells of different origin by professional and nonprofessional phagocytes. Cell Death Differ. 14, 1117-1128 (Pubitemid 46785103)
123. Sipione, S., Ewen, C., Shostak, I., Michalak, M., and Bleackley, R. C. (2005) Impaired cytolytic activity in calreticulin-deficient CTLs. J. Immunol. 174, 3212-3219 (Pubitemid 40354023)
124. Obeid, M. (2009) Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin-inducer peptides. Mol. Cancer Ther. 8, 2693-2707
125. Corbett, E. F., Michalak, K. M., Oikawa, K., Johnson, S., Campbell, I. D., Eggleton, P., Kay, C., and Michalak, M. (2000) The conformation of calreticulin is influenced by the endoplasmic reticulum luminal environment. J. Biol. Chem. 275, 27177-27185
126. Basu, S., Binder, R. J., Suto, R., Anderson, K. M., and Srivastava, P. K. (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12, 1539-1546
127. Cheng, C. F., Fan, J., Fedesco, M., Guan, S., Li, Y., Bandyopadhyay, B., Bright, A. M., Yerushalmi, D., Liang, M., Chen, M., Han, Y. P., Woodley, D. T., and Li, W. (2008) Transforming growth factor alpha (TGFα)-stimulated secretion of HSP90α: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFβ-rich environment during wound healing. Mol. Cell. Biol. 28, 3344-3358 (Pubitemid 351657098)
128. Hegmans, J. P., Gerber, P. J., and Lambrecht, B. N. (2008) Exosomes Methods Mol. Biol. 484, 97-109
129. Yu, X., Harris, S. L., and Levine, A. J. (2006) The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 66, 4795-4801
130. Denzer, K., Kleijmeer, M. J., Heijnen, H. F., Stoorvogel, W., and Geuze, H. J. (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113, 3365-3374
131. Stoorvogel, W., Kleijmeer, M. J., Geuze, H. J., and Raposo, G. (2002) The biogenesis and functions of exosomes. Traffic 3, 321-330
132. Fevrier, B., and Raposo, G. (2004) Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 16, 415-421
133. Afshar, N., Black, B. E., and Paschal, B. M. (2005) Retrotranslocation of the chaperone calreticulin from the endoplasmic reticulum lumen to the cytosol. Mol. Cell. Biol. 25, 8844-8853
134. Rabek, J. P., Boylston, W. H., 3rd, and Papaconstantinou, J. (2003) Carbonylation of ER chaperone proteins in aged mouse liver. Biochem. Biophys. Res. Commun. 305, 566-572
135. Oyadomari, S., Takeda, K., Takiguchi, M., Gotoh, T., Matsumoto, M., Wada, I., Akira, S., Araki, E., and Mori, M. (2001) Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc. Natl. Acad. Sci. U. S. A. 98, 10845-10850
136. Xu, F. F., Liu, X. H., and Zhu, X. M. (2008) [Calreticulin upregulation induced by hypoxic preconditioning relieves oxidative stress injury in rat cardiomyocytes.] Sheng Li Xue Bao 60, 29-37
137. Caramelo, J. J., and Parodi, A. J. (2008) Getting in and out from calnexin/calreticulin cycles. J. Biol. Chem. 283, 10221-10225
138. Shaffer, K. L., Sharma, A., Snapp, E. L., and Hegde, R. S. (2005) Regulation of protein compartmentalization expands the diversity of protein function. Dev. Cell. 9, 545-554
139. Decca, M. B., Carpio, M. A., Bosc, C., Galiano, M. R., Job, D., Andrieux, A., and Hallak, M. E. (2007) Post-translational arginylation of calreticulin: a new isospecies of calreticulin component of stress granules. J. Biol. Chem. 282, 8237-8245
140. Keller, M., Ruegg, A., Werner, S., and Beer, H. D. (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818-831
141. Freikman, I., Amer, J., Ringel, I., and Fibach, E. (2009) A flow cytometry approach for quantitative analysis of cellular phosphatidylserine distribution and shedding. Anal. Biochem. 393, 111-116
142. Mirnikjoo, B., Balasubramanian, K., and Schroit, A. J. (2009) Suicidal membrane repair regulates PS externalization during apoptosis. J. Biol. Chem. 284, 22512-22516
143. Patel, J. M., Li, Y. D., Zhang, J., Gelband, C. H., Raizada, M. K., and Block, E. R. (1999) Increased expression of calreticulin is linked to ANG IV-mediated activation of lung endothelial NOS. Am. J. Physiol. Lung Physiol. 277, L794-L801 (Pubitemid 29522646)
144. Arispe, N., Doh, M., Simakova, O., Kurganov, B., and De Maio, A. (2004) Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability. FASEB J. 18, 1636-1645
145. Muller-Taubenberger, A., Lupas, A. N., Li, H., Ecke, M., Simmeth, E., and Gerisch, G. (2001) Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis. EMBO J. 20, 6772-6782
146. Gagnon, E., Duclos, S., Rondeau, C., Chevet, E., Cameron, P. H., Steele-Mortimer, O., Paiement, J., Bergeron, J. J., and Desjardins, M. (2002) Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119-131
147. Elliott, T., and Williams, A. (2005) The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunol. Rev. 207, 89-99
148. Madeo, F., Durchschlag, M., Kepp, O., Panaretakis, T., Zitvogel, L., Frohlich, K. U., and Kroemer, G. (2009) Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals. Cell Cycle 8, 639-642
149. Macario, A. J., and De Macario, E. C. (2007) Chaperonopathies by defect, excess, or mistake. Ann. N. Y. Acad. Sci. 1113, 178-191
150. Tsutsumi, S., and Neckers, L. (2007) Extracellular heat shock protein 90: A role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci. 98, 1536-1539
151. Li, W., Li, Y., Guan, S., Fan, J., Cheng, C. F., Bright, A. M., Chinn, C., Chen, M., and Woodley, D. T. (2007) Extracellular heat shock protein-90α: linking hypoxia to skin cell motility and wound healing. EMBO J. 26, 1221-1233
152. Multhoff, G. (2007) Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods 43, 229-237
153. Schmitt, E., Gehrmann, M., Brunet, M., Multhoff, G., and Garrido, C. (2007) Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J. Leukoc. Biol. 81, 15-27 (Pubitemid 46021247)
154. Basu, S., Binder, R. J., Ramalingam, T., and Srivastava, P. K. (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14, 303-313
155. Datta, G., Chaddha, M., Garber, D. W., Chung, B. H., Tytler, E. M., Dashti, N., Bradley, W. A., Gianturco, S. H., and Anantharamaiah, G. M. (2000) The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts. Biochemistry 39, 213-220
156. Galiano, R. D., Michaels, J., Dobryansky, M., Levine, J. P., and Gurtner, G. C. (2004) Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen. 12, 485-492
157. Ito, M., Yang, Z., Andl, T., Cui, C., Kim, N., Millar, S. E., and Cotsarelis, G. (2007) Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 447, 316-320
158. Kageyama, S., Isono, T., Matsuda, S., Ushio, Y., Terai, A., Arai, Y., Kawakita, M., Okada, Y., and Yoshiki, T. (2009) Urinary calreticulin in the diagnosis of bladder uroethelial carcinoma. Int. J. Urol. 16, 481-486
159. Goeb, V., Thomas-L'Otellier, M., Daveau, R., Charlionet, R., Fardellone, P., Le Loet, X., Tron, F., Gilbert, D., and Vittecoq, O. (2009) Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res. Ther. 11, R38
160. Sanchez, D., Palova-Jelinkova, L., Felsberg, J., Simsova, M., Pekarikova, A., Pecharova, B., Swoboda, I., Mothes, T., Mulder, C. J., Benes, Z., Tlasklova-Hogenova, H., and Tuckova, L. (2008) Anti-calreticulin immunoglobulin A (IgA) antibodies in refractory celiac disease. Clin. Exp. Immunol. 153, 351-359
161. Gu, V. Y., Wong, M. H., Stevenson, J. L., Crawford, K. E., Brennecke, S. P., and Gude, N. M. (2008) Calreticulin in human pregnancy and pre-eclampsia. Mol. Hum. Reprod. 14, 309-315
162. Watanabe, L., Ohira, H., Orikasa, H., Saito, K., Kanno, K., Shioya, Y., Obara, K., and Sato, Y. (2006) Anti-calreticulin antibodies in patients with inflammatory bowel disease. Fukushima J. Med. Sci. 52, 1-11
163. Kageyama, S., Isono, H., Wakabayashi, Y., Okada, Y., Kontani, K., Yoshimura, K., Terai, A., Arai, Y., and Yoshiki, T. (2004) Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin. Chem. 50, 857-866
164. Taguchi, J., Fujino, Y., Tsujioka, Y., Takahashi, M., Tsuboi, Y., Wada, I., and Yamada, T. (2000) Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain. Acta Neuropathol. 100, 153-160 (Pubitemid 30456137)
165. Kreisel, W., Siegel, A., Bahler, A., Spamer, C., Schiltz, E., Kist, M., Seilnacht, G., Klein, R., Berg, P. A., and Heilmann, C. (1999) High prevalence of antibodies to calreticulin of the IgA class in primary biliary cirrhosis: a possible role of gut-derived bacterial antigens in its aetiology? Scand. J. Gastroenterol. 34, 623-628
166. Vandivier, R. W., Ogden, C. A., Fadok, V. A., Hoffmann, P. R., Brown, K. K., Botto, M., Walport, M. J., Fisher, J. H., Henson, P. M., and Greene, K. E. (2002) Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169, 3978-3986
167. Dai, E., Stewart, M., Ritchie, B., Mesaeli, N., Raha, S., Kolodziejczyk, D., Hobman, M. L., Liu, L. Y., Etches, W., Nation, N., Michalak, M., and Lucas, A. (1997) Calreticulin, a potential vascular regulatory protein, reduces intimal hyperplasia after arterial injury. Arterioscler. Thromb. Vasc. Biol. 17, 2359-2368 (Pubitemid 28015968)